ASCO also recognizes that the varying levels of vaccine uptake around the world need to be raised so that all women are receiving preventative services. To this end, in March 2017, ASCO issued an evidence-based clinical practice guideline on the use of the HPV vaccine for preventing cervical cancer aimed at physicians in various resource settings around the world. To reduce the incidence of cervical cancer globally, the guideline recommends:
The recommendations were then broken down for settings with limited, basic, maximal, and enhanced resources.
Watch a video about ASCO's recommendations for reducing the global burden of cervical cancer.
Related resources from Cancer.Net, ASCO's patient information website: